Source:http://linkedlifedata.com/resource/pubmed/id/18288103
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
9
|
pubmed:dateCreated |
2008-4-16
|
pubmed:abstractText |
Increased demand for amino acids to sustain acute-phase protein synthesis could be the stimulus for the increased muscle protein catabolism during hemodialysis (HD). This could be attenuated by intradialytic amino-acid infusion. To test this, we measured the fractional synthesis rates of albumin, fibrinogen, and muscle protein in eight patients with end-stage renal disease at baseline before dialysis and during HD without or with amino-acid infusion. The percentage change in the fractional synthesis rates of albumin, fibrinogen, and muscle protein from baseline was significantly higher during HD with amino-acid infusion than without amino-acid infusion. Leg muscle proteolysis was significantly increased during unsupplemented HD compared with baseline, but this was not decreased by amino-acid infusion. Arteriovenous balance studies across the leg showed a net efflux of interleukin-6 (IL-6) from the muscle into the vein during HD. The fractional synthesis rate of albumin, fibrinogen, and muscle protein correlated with each other and with the IL-6 efflux from the leg. Leg muscle protein catabolism was positively related to IL-6 release from the leg and not associated with amino-acid availability. Our results show that intradialytic cytokine activation and not amino-acid depletion is the major protein catabolic signal during HD.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Albumins,
http://linkedlifedata.com/resource/pubmed/chemical/Amino Acids,
http://linkedlifedata.com/resource/pubmed/chemical/Cytokines,
http://linkedlifedata.com/resource/pubmed/chemical/Fibrinogen,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-6,
http://linkedlifedata.com/resource/pubmed/chemical/Muscle Proteins
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
1523-1755
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
73
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1054-61
|
pubmed:meshHeading |
pubmed-meshheading:18288103-Adult,
pubmed-meshheading:18288103-Albumins,
pubmed-meshheading:18288103-Amino Acids,
pubmed-meshheading:18288103-Cytokines,
pubmed-meshheading:18288103-Female,
pubmed-meshheading:18288103-Fibrinogen,
pubmed-meshheading:18288103-Humans,
pubmed-meshheading:18288103-Interleukin-6,
pubmed-meshheading:18288103-Kidney,
pubmed-meshheading:18288103-Kidney Failure, Chronic,
pubmed-meshheading:18288103-Male,
pubmed-meshheading:18288103-Muscle Proteins,
pubmed-meshheading:18288103-Renal Dialysis
|
pubmed:year |
2008
|
pubmed:articleTitle |
Interleukin-6 modulates hepatic and muscle protein synthesis during hemodialysis.
|
pubmed:affiliation |
Division of Nephrology and Epidemiology, University of New Mexico Health Sciences Center, Albuquerque, New Mexico 87131-5271, USA. draj@salud.unm.edu
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Research Support, N.I.H., Extramural
|